ArticleInternational ophthalmology2020
Complications of femtosecond laser-assisted cataract surgery combined with vitrectomy.
Article in International ophthalmology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 4 citations in OpenAlex.
- Evaluation of Tilt and Decentration of Intraocular Lens After Combined Femtosecond Laser-Assisted Cataract Surgery and Vitrectomy.Journal of ophthalmology · 2026Article
- Femtosecond Laser-Assisted Cataract Surgery versus Conventional Phacoemulsification Combined with Vitrectomy for Cataract Complicated with Fundus Disease: Superior Efficacy in Patients with Vitreous Opacity and Cost-Effectiveness Analysis.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Factors Associated With Postoperative Outcomes in Femtosecond Laser-Assisted Cataract Surgery.Cureus · 2025Article
- Macular pucker and cataract treated with phacoemulsification and IOL implantation combined with small-gauge pars plana vitrectomy: a comparison of outcomes with and without femtosecond laser assistance.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the safety of femtosecond laser-assisted cataract surgery (FLACS) combined with 25- or 27-gauge vitrectomy.
methodsThis retrospective study included patients who underwent FLACS combined with 25- or 27-gauge vitrectomy at the Jikei University School of Medicine in Tokyo, Japan, between August 2016 and April 2018 and were followed up for ≥ 3 months postoperatively. In all cases, anterior capsulotomies and fragmentations of crystalline lenses were performed using a femtosecond laser. After FLACS, 25- or 27-gauge vitrectomy was performed. All intraoperative and postoperative complications due to FLACS and vitrectomy were examined.
resultsA total of 34 eyes from 34 patients were included. In 33 cases, complete coverage of the intraocular lens (IOL) by the anterior capsular edge was achieved. One case had posterior capsule rupture due to mis-suction during emulsification and aspiration of a fragment of the nuclear lens after capsulotomy. The IOL was fixed at the sulcus. Postoperative complications included endophthalmitis and macular edema in one eye, epiretinal membranes in two eyes, and postoperative capsular opacification in two eyes. The femtosecond laser caused no postoperative complications. There were no cases of intraoperative or postoperative iris capture or IOL subluxation.
conclusionsIn most cases, FLACS provided good IOL fixation in the capsule without affecting the intra- or extraocular pressure and good vision during or after the operation. FLACS combined with 25- or 27-gauge vitrectomy should be performed considering the advantages and disadvantages of femtosecond laser usage. CLINICAL
trial registrationJapan Clinical Trials Register; number: UMIN000021814.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.